19 Jun, 2013
The Leela Palace, Bengaluru
Monday, November 5, 2012 - 18:32 IST
EILSF exits Sutures India with 3.2x returns as CX Partners buys stake for $37M
BY Madhav A Chanchani & Bhawna Gupta
The fund has few more exits in the pipeline and expects to close at least one more in the next six months.
Life Sciences-focused private equity fund EILSF (Evolvence India Life Sciences Fund) has exited Sutures India Private Limited with cash on cash returns of 3.2x on its three-year-old investment, according to a top official. EILSF sold its stake...
To continue reading this article, you must be a Premium subscriber...
A Premium membership gives you:
- Access to all premium articles including exclusives, analyses & commentary.
- Access to archives of over six years.
- Exclusive interviews with top fund managers, CEOs and bankers.
JOBS
- Associate - Red Fort Capital Advisors Pvt Ltd
- The Private Equity Associate - Nereus Capital
RECENT COMMENTS
- 21 May 2013PhoenixonWell said Varadha. This comment of your is unclear, " LPs ought to maintain an arm's distance from GPs and...
- 21 May 2013AnooponThe biggest problem in Indian PE fund GPs is Ethics. They want Day-One-Carry rather than long term carry. There should...
- 20 May 2013varadhaonExits are not happening because a lot of businesses that PE funds invested into were not worthy of investments in the...
- 17 May 2013Santosh VermaonMohanjit, You have the ability to say something that can be said in 100 words in 5,000 words. Congrats on a well...
UPCOMING EVENTSchinetwork